Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Logistic model for prevalence use in lifetime and last month among males and females

From: The application of observational data in translational medicine: analyzing tobacco-use behaviors of adolescents

Lifetime use
  Males (M) Females (F)
Parameter OR (CI 0.95) p-value OR (CI 0.95) p-value
Trend 2000–2005 (one year) 0.95 (0.94;0.96) *** 0.96 (0.95;0.96) ***
Trend 2005–2010 (one year) 1.04 (1.03;1.04) *** 1.05 (1.04;1.06) ***
Age (one year) 1.30 (1.29;1.31) *** 1.27 (1.26;1.28) ***
(Risk & No Availability) vs (No Risk & No Availability) 0.59 (0.56;0.63) *** 0.63 (0.60;0.67) ***
(No Risk & Availability) vs (No Risk & No Availability) 3.59 (3.42;3.76) *** 4.71 (4.47;4.97) ***
(Risk & Availability) vs (No Risk & No Availability) 2.44 (2.33;2.55) *** 2.93 (2.79;3.08) ***
Last month use
Parameter OR (CI 0.95) p-value OR (CI 0.95) p-value
Trend 2000–2005 (one year) 0.99 (0.98;1.00) n.s. 1.00 (0.99;1.01) n.s.
Trend 2005–2010 (one year) 1.00 (0.99;1.01) n.s. 1.00 (0.99;1.00) n.s.
Age (one year) 1.30 (1.29;1.31) *** 1.17 (1.16;1.18) ***
(Risk & No Availability) vs (No Risk & No Availability) 0.51 (0.47;0.55) *** 0.53 (0.48;0.57) ***
(No Risk & Availability) vs (No Risk & No Availability) 3.55 (3.34;3.76) *** 4.82 (4.51;5.15) ***
(Risk & Availability) vs (No Risk & No Availability) 2.31 (2.18;2.44) *** 2.98 (2.80;3.18) ***
  1. Odds Ratio (OR), Confidential Interval (CI).
  2. *p < 0.05; **p < 0.01; ***p < 0.001.